tegafur has been researched along with Pleural Effusion, Malignant in 4 studies
Pleural Effusion, Malignant: Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A second-line chemotherapy for advanced gastric cancer has not been established." | 1.32 | [A case of recurrent pleural effusion and positive cytology of advanced gastric cancer treated by TS-1 plus weekly taxane as second-line chemotherapy]. ( Akiba, Y; Hibi, T; Hosoe, N; Ishii, H; Izumiya, M; Mori, S; Nagata, H; Suzuki, J; Takaishi, H; Ueda, T; Yamagishi, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, Y | 1 |
| Koshohbu, T | 1 |
| Nakatani, S | 1 |
| Matsumoto, S | 1 |
| Yasuda, K | 1 |
| Hitsuda, Y | 1 |
| Shimizu, E | 1 |
| Arai, W | 1 |
| Hosoya, Y | 1 |
| Yokoyama, T | 1 |
| Saito, S | 1 |
| Hirashima, Y | 1 |
| Hyodo, M | 1 |
| Yasuda, Y | 1 |
| Nagai, H | 1 |
| Shirasaka, T | 1 |
| Akiba, Y | 1 |
| Yamagishi, Y | 1 |
| Mori, S | 1 |
| Ueda, T | 1 |
| Suzuki, J | 1 |
| Hosoe, N | 1 |
| Izumiya, M | 1 |
| Takaishi, H | 1 |
| Nagata, H | 1 |
| Hibi, T | 1 |
| Ishii, H | 1 |
| Iwatsuki, M | 1 |
| Kuramoto, M | 1 |
| Ishihara, K | 1 |
| Ikeshima, S | 1 |
| Hasuo, T | 1 |
4 other studies available for tegafur and Pleural Effusion, Malignant
| Article | Year |
|---|---|
[Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administra | 2003 |
[A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administration Sc | 2004 |
[A case of recurrent pleural effusion and positive cytology of advanced gastric cancer treated by TS-1 plus weekly taxane as second-line chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-19-9 Antigen; Doce | 2004 |
[A case of unresectable non-small cell lung cancer with pleural dissemination successfully treated with DIF].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 2006 |